Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030

icon1
USD 9.35 BN
MARKET SIZE, 2030
icon2
CAGR 6.8%
(2024-2030)
icon3
354
REPORT PAGES
icon4
350
MARKET TABLES

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The medical filtration market is projected to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8% from 2024 to 2030. The medical filtration market is experiencing steady growth worldwide. This expansion is driven by the rising need for infection control, stricter regulatory standards, and increasing healthcare infrastructure investments, particularly in emerging economies

KEY TAKEAWAYS

  • BY APPLICATION
    The medical filtration market by application type include dialysis, drug delivery, IV infusion & sterile filtration, endoscopy, sterile processing, bio-artificial process and other applications. Dialysis represents the largest application segment in the medical filtration market due to the critical need for high-performance filters in blood purification processes. Filtration is essential in dialysis machines to remove waste products, toxins, and excess fluids from the bloodstream while maintaining sterility and preventing contamination. The growing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), coupled with an aging population, has significantly increased the demand for dialysis treatments worldwide.
  • BY DESIGN/PROCESS
    The medical filtration market by design/process include systems, consumables (Filtration Modules), and others. Consumables, particularly filtration modules, represent the largest design or process type segment in the medical filtration market. These components are essential for maintaining sterile conditions in various medical and pharmaceutical applications, including dialysis, drug production, and laboratory processes. Their dominance is driven by their high replacement rate, cost-effectiveness, and widespread use across multiple end-use areas.
  • BY MATERIAL
    The medical filtration market by material type include PSU &PES, PVDF, PTFE, PP and other materials. Polysulfone (PSU) and polyethersulfone (PES) are the leading material types in the medical filtration market due to their superior mechanical strength, thermal stability, and biocompatibility. These polymers are widely used in membrane production for applications such as dialysis, sterile filtration, and biopharmaceutical processing. Their excellent chemical resistance and ability to withstand repeated sterilization cycles make them ideal for both reusable and disposable filtration systems
  • BY PROCESS TECHNOLOGY
    The medical filtration market by process technology include ultrafiltration, microfiltration, nanofiltration, reversis osmosis, gas filtration and others. Microfiltration is the largest process technology segment in the medical filtration market, primarily due to its extensive use in removing bacteria, suspended particles, and other contaminants while maintaining essential biological components. It is widely applied in pharmaceutical manufacturing, sterile filtration of liquids, and hospital settings to ensure high levels of purity and safety. The technology’s versatility, cost-effectiveness, and compatibility with various materials such as PES and PVDF make it a preferred choice across multiple applications.
  • BY End-use Industry
    The medical filtration market by end-use industry include hospitals, diagnostics centers, research institutes and others. Hospitals represent the largest end-use segment in the medical filtration market, driven by the critical need for maintaining sterile and contamination-free environments. The growing number of hospitals, rising healthcare expenditures, and increasing focus on preventing hospital-acquired infections (HAIs) further boost demand.
  • BY REGION
    The medical filtration market covers Europe, North America, Asia Pacific, South America, the Middle East, and Africa. North America holds the largest share of the medical filtration market, supported by its well-established healthcare infrastructure, stringent regulatory standards, and strong focus on infection prevention and control. The region’s advanced medical facilities, high adoption of cutting-edge filtration technologies, and significant investments in R&D contribute to sustained market dominance. Additionally, the growing prevalence of chronic diseases and the presence of major medical device and filtration manufacturers drive consistent demand..
  • COMPETITIVE LANDSCAPE
    Major market players have adopted both organic and inorganic strategies, including partnerships and investments. Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc. (US), Donaldson Company Inc. (US), Baxter (US), Parker Hannifin Corp. (US), Entegris (US), Asahi Kasei Corporation (Japan), and MANN+HUMMEL (Germany) are som of the major players in the medical filtration market.

The medical filtration market is witnessing strong global growth, driven by increasing healthcare investments, stricter infection control regulations, and heightened awareness following recent pandemics. Advanced filtration systems are becoming essential across hospitals, laboratories, and pharmaceutical manufacturing facilities to ensure clean and sterile environments. Regionally, Asia-Pacific is the fastest-growing market due to rapid healthcare expansion, while North America and Europe remain mature markets with steady demand driven by technological innovation and regulatory compliance.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Changes in customer trends or disruptions impact consumers’ businesses. These shifts impact the revenues of end users. Consequently, the revenue impact on end users is expected to affect the revenues of medical filtration products suppliers, which, in turn, impacts the revenues of medical filtration product manufacturers.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing demand for high-quality filtration solutions
  • Rising awareness of infection control
RESTRAINTS
Impact
Level
  • High cost of advanced filtration systems.
  • Stringent regulatory compliance
OPPORTUNITIES
Impact
Level
  • Advancments in filtration technologies
  • Growing healthcare investments
CHALLENGES
Impact
Level
  • Disposal of filters

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing demand for high-quality filtration solutions

The growing demand for high-quality filtration solutions is a major driver for the medical filtration market, fueled by the increased demand for safety and efficacy standards in healthcare applications. This industry is primarily responsible for expanding the scope of using reliable filtration technologies to ensure the purity of fluids used in research and clinical settings. Effective filtration is also considered necessary to comply with stringent regulatory requirements by governing agencies like the FDA and EMA to ensure high-quality standards for medical products. Continuous improvement in filtration technologies, including nanofiltration and membrane systems, enhances the accuracy and efficiency levels, resulting in the development of solutions that can perform well in critical applications, such as IV infusions and sterile processing. Key companies have shifted their focus toward growth opportunities by innovating and developing specialized filtration products to cater to changing demands from healthcare providers and research institutes. The emphasis on sustainability is further aiding the development of environmentally friendly filtration solutions. Because of the global shift in habits toward sustainable practices, the continuing dependence of the health sector on patient safety and product integrity will ensure continuing growth in demand for high-quality medical filtration solutions

Restraint: High cost of advanced filtration systems

The high cost of filtration systems is a critical restraint for the medical filtration market. While these systems are necessary for ensuring the purity and safety of medical products, they place a large capital investment burden on organizations and may be very expensive to install in smaller healthcare facilities and research institutes. For example, the installation cost for microfiltration and ultrafiltration systems may lie between thousands of dollars and millions of dollars, depending on their complexity and volume. Additionally, maintenance and operational costs are also considerable, especially in areas where finances are already depleted. For example, critical area filters like those for operation rooms and ICUs must be serviced frequently to keep them performing at their best; these add to the operating costs. Specialized materials and technologies, such as high-performance membranes that can withstand a strict sterilization cycle, add up to these operating costs. Therefore, most prospective users may not invest in such advanced filtration systems on time, thus negatively affecting the market. Additionally, it may discourage facilities from implementing new systems if their integration proves complicated. It then presents a very difficult environment that calls for companies to be more innovative with solutions but still work under the budget constraints of the customer

Opportunity: Advancements in filtration technologies

Advancements in filtration technologies provide significant opportunities to the medical filtration market through innovation and development for application in various fields across the healthcare industry. Developments in the last decade from material science fields have seen great progress in new technologies, such as the development of nanofiber and electrospun filters. The latter technology was the game changer, making filtration systems capture small particles and even pathogens more effectively. Such inventions have led to the development of filters that have better protection for airborne viruses, bacteria, and other contaminants to improve patient safety and infection control in health facilities. Another opportunity derives from the increasing demand for green filtration technology. The drive toward a green material and a reusable or recyclable filter corresponds to global trends in sustainability in the healthcare sector. Medical filtration companies are increasingly looking at systems that cut energy consumption, reduce waste, and are environmentally friendly, thereby opening new markets, especially areas with increasing awareness of an environment-friendly environment. Moreover, stringent regulations in the healthcare sector have created a need for more sterilization and tighter contaminant control, which results in the demand for advanced filtration equipment to meet current standards

Challenge: Disposal of filters

One of the main challenges for the medical filtration market remains the disposal of the filters used in medical filtration. Above all, it is associated with the complexities of medical waste disposal. Filters, especially in sterile applications, become contaminated with hazardous materials such as pathogens and chemical residues, requiring careful handling and disposal to avoid health risks. It further complicates the process because a high volume of medical waste and stringent regulatory requirements for disposal are involved. Many existing disposal methods like incineration and landfilling have raised more environmental concerns due to possible emissions of toxic substances and the risk of contaminating soil and water sources. The lack of a standardized protocol to sort and recycle medical filters increases inefficiencies, which is the reason that escalates costs at healthcare facilities. Therefore, it is imperative that companies operating within the medical filtration market push sustainable disposal solutions both in relation to compliance and a reduction in their environmental impact. This situation has created a need for innovative approaches, such as recycling programs for reclaiming materials safely from used filters in healthcare settings without compromising public health. Addressing these challenges effectively is important for establishing a more sustainable medical filtration industry and improving the overall waste management practices in healthcare settings

Medical Filtration Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Uses high-purity dialysis filtration systems for blood purification and water treatment. Ensures sterile, contaminant-free dialysis water; reduces infection risk; supports patient safety and consistent treatment outcomes.
Utilizes ultrafiltration membranes for water purification and dialysis fluid management. Provides reliable, sterile dialysis water; improves patient outcomes; reduces machine downtime.
Uses membrane filtration systems for sample preparation and contamination prevention Ensures test accuracy, sterile sample handling, and regulatory compliance.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The medical filtration ecosystem analysis involves identifying and analyzing interconnected relationships among various stakeholders, including raw material supplies, equipment suppliers, manufacturers, distributors, and end users. The raw material suppliers provide filters, membrane materials, and others to medical filtration manufacturers. The distributors and suppliers establish contact between the manufacturing companies and end users to streamline the supply chain, increasing operational efficiency and profitability.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Medical Filtration Market, By Application

Dialysis accounts for the largest market share of the medical filtration market, mainly due to the rising cases of chronic kidney disease and end-stage renal disease. The increasing global prevalence of kidney-related conditions, mainly attributed to the increasing cases of diabetes and hypertension—two leading risk factors for CKD—has led to an increased demand for dialysis treatments. Since dialysis filtration is the replacement of kidney function when the kidneys fail by removing waste and toxins from the blood, it is an inevitable necessity for patients with end-stage renal diseases. Technological advancements in dialysis filtration systems have increased the efficiency of treatment, decreased complications, and improved comfort for patients, leading to its wide adoption, such as high-flux and low-flux membranes. The two major modalities, hemodialysis and peritoneal dialysis, depend on advanced filtration technologies for both safety and efficacy. The global aging population has increased the demand for them since older adults have been increasingly found to be at an increased risk of getting kidney diseases and complications. In addition, the growth in the number of dialysis centers, home-based dialysis options, and government initiatives that facilitate access to dialysis care have further driven the growth of the market. The other factor is the frequency of dialysis treatment. Since patients require a number of sessions per week, the service creates a fairly consistent demand in terms of requirements for consumable items such as filters, membranes, and cartridges, thus stabilizing its position in the market

Medical Filtration Market, By Process Technology

Ultrafiltration held the second largest market share by process technology because it allows better efficiency with high versatility, coupled with the very critical application scope across several segments of health sciences. The mechanism of ultrafiltration involves the filtration of bacteria and viruses as well as other lethal pyrogens through semipermeable membranes while holding valuable proteins and other nutrients intact, which makes this choice appropriate for health and pharmaceutical streams. It finds applications in many critical operations like dialysis, blood purification, and preparation of intravenous fluids. Ultrafiltration is vital to remove excess fluid in the case of dialysis without letting go of electrolyte balance or other critical solutes, hence improving the efficacy of treatment. Ongoing innovations and advancements in membrane materials and designs have improved the efficiency and durability of ultrafiltration systems, thereby lowering the cost and making them available to both developed and emerging markets. The growing need for minimally invasive and highly effective treatments in the healthcare sector, combined with strict regulatory requirements for sterility and contamination control, has intensified the application of ultrafiltration in various healthcare facilities

REGION

Asia Pacifi to be fastest-growing region in global medical filtration market during forecast period

The Asia Pacific is the fastest-growing market for medical filtration because of demographic, economic, and healthcare advances. The rapidly growing population, mainly in countries such as China, India, and countries in Southeast Asia, is also supporting the growth of the healthcare market in the region. The rising geriatric population facing chronic diseases like kidney disease, cardiovascular conditions, and diabetes are the biggest drivers for advanced medical filtration solutions in the region. The growing focus on infection control has significantly increased demand for sterility-based medical devices and filtration technologies to deliver contamination-free treatments without affecting the patient’s safety. Economic growth in the Asia Pacific has led to investment in healthcare infrastructure and the growth of medical services. The heavy investments by government and private sectors in healthcare and research facilities, especially in developing economies, are further boosting market growth. Asia Pacific has remained the hub of drug manufacturing and clinical trials primarily due to cost advantages and the availability of a skilled workforce. The demand for ultrafiltration and microfiltration solutions in the drug formulation and sterile processing stages has increased. More recently, awareness of infection prevention and cross-contamination in healthcare has promoted the adoption of filtration technologies. Increased healthcare spending, advances in medical technology, and increased focus on improving patient care have resulted in the high growth of the Asia Pacific medical filtration market.

Medical Filtration Market: COMPANY EVALUATION MATRIX

In the medical filtration market matrix, Merck (Star), a US based company, leads the market through its high-quality medical filtration products, which find extensive applications in various applications such as dialysis machine, drug delivery and others.MANN+HUMMEL (Emerging Leader) is gaining traction with its technological advancements in medical filtration.

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 6.29 Billion
Market Forecast in 2030 (Value) USD 9.35 Billion
Growth Rate CAGR of 6.8% from 2024-2030
Years Considered 2021-2030
Base Year 2023
Forecast Period 2024-2030
Units Considered Value (USD Million/Billion), Volume (Unit)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Material:
    • PSU & PES
    • PVDF
    • PTFE
    • PP
    • Other Materials
  • By Process Technology:
    • Ultrafiltration
    • Microfiltration
    • Nanofiltration
    • Reverse Osmosis
    • Gas Filtration
    • Other Process Technologies
  • By Design/Process:
    • Systems (RTU Units)
    • Consumables (Filtration Modules)
    • Other Design/Process.
  • By End-use Industry:
    • Hospitals
    • Diagnostics Centers
    • Research Institutes and other End-use Industries.
Regions Covered North America, Asia Pacific, Europe, South America, Middle East & Africa

WHAT IS IN IT FOR YOU: Medical Filtration Market REPORT CONTENT GUIDE

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Leading Medical Filtration Produts Supplier
  • Competitive profiling of medical filtration products suppliers (financials, certifications, product portfolio)
  • Partnership and supply chain ecosystem analysis
Supported go-to-market strategy and positioning vs competitors
Country-level insights for high-growth regions Provided detailed market sizing and forecasts for the U.S., Germany, China, India, and Japan Helped the client identify region-specific growth hotspots and investment opportunities

RECENT DEVELOPMENTS

  • September 2024 : Sartorius AG launched Vivaflow SU, setting a new standard in tangential flow filtration (TFF) for laboratories
  • April 2024 : 3M completed the spin-off of its healthcare business, forming Solventum Corporation as an independent company
  • May 2023 :    Cytiva and Pall Corporation’s life sciences business merged under the Cytiva brand.
  • May 2022 : Merck KGaA invested around USD 453 million to expand its membrane and filtration manufacturing in Cork, Ireland
  • March 2020 : Danaher completed the acquisition of its Biopharma business from General Electric company’s life Science Business division

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
32
2
RESEARCH METHODOLOGY
 
 
 
36
3
EXECUTIVE SUMMARY
 
 
 
46
4
PREMIUM INSIGHTS
 
 
 
50
5
MARKET OVERVIEW
Advanced healthcare demand and AI integration drive market growth despite investment and compliance challenges.
 
 
 
53
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
INCREASING DEMAND FOR ADVANCED HEALTHCARE SOLUTIONS
 
 
 
 
5.2.1.2
RISING AWARENESS OF INFECTION CONTROL
 
 
 
 
5.2.1.3
TECHNOLOGICAL ADVANCEMENTS
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH CAPITAL INVESTMENTS
 
 
 
 
5.2.2.2
STRINGENT REGULATORY COMPLIANCE
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
GROWING HEALTHCARE INVESTMENTS IN EMERGING ECONOMIES
 
 
 
 
5.2.3.2
ADOPTION OF SINGLE-USE TECHNOLOGIES
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
SPEED AND YIELD ISSUES
 
 
5.3
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.3.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.3.2
THREAT OF SUBSTITUTES
 
 
 
 
5.3.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.3.4
BARGAINING POWER OF BUYERS
 
 
 
 
5.3.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.4
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.4.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.4.2
QUALITY
 
 
 
 
5.4.3
SERVICE
 
 
 
5.5
MACROECONOMIC OUTLOOK
 
 
 
 
 
5.5.1
GDP TRENDS AND FORECASTS
 
 
 
5.6
IMPACT OF AI/GEN AI
 
 
 
 
 
5.7
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.7.1
RAW MATERIAL SUPPLIERS
 
 
 
 
5.7.2
MANUFACTURERS
 
 
 
 
5.7.3
DISTRIBUTORS
 
 
 
 
5.7.4
END USERS
 
 
 
5.8
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.9
CASE STUDY ANALYSIS
 
 
 
 
 
5.9.1
VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS
 
 
 
 
5.9.2
ENHANCING DIALYSIS FILTRATION EFFICIENCY – FRESENIUS MEDICAL CARE
 
 
 
 
5.9.3
BLOOD FILTRATION FOR SEPSIS TREATMENT – CYTOSORBENTS CORPORATION
 
 
 
5.10
TARIFF AND REGULATORY LANDSCAPE
 
 
 
 
 
 
5.10.1
ENVIRONMENTAL REGULATIONS
 
 
 
 
5.10.2
NORTH AMERICA
 
 
 
 
5.10.3
ASIA PACIFIC
 
 
 
 
5.10.4
EUROPE
 
 
 
 
5.10.5
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.11
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.11.1
KEY TECHNOLOGIES
 
 
 
 
 
5.11.1.1
MICROFILTRATION
 
 
 
 
5.11.1.2
ULTRAFILTRATION
 
 
 
 
5.11.1.3
NANOFILTRATION
 
 
 
5.11.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.11.2.1
SINGLE-USE TECHNOLOGY
 
 
 
5.11.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.11.3.1
CHROMATOGRAPHY
 
 
5.12
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
5.13
TRADE ANALYSIS
 
 
 
 
 
 
5.13.1
EXPORT SCENARIO (HS CODE 8421)
 
 
 
 
5.13.2
IMPORT SCENARIO (HS CODE 8421)
 
 
 
5.14
KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
5.15
PRICING ANALYSIS
 
 
 
 
 
 
5.15.1
AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023
 
 
 
 
5.15.2
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023
 
 
 
 
5.15.3
AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023
 
 
 
5.16
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.17
PATENT ANALYSIS
 
 
 
 
 
 
5.17.1
INTRODUCTION
 
 
 
 
5.17.2
LEGAL STATUS OF PATENTS
 
 
 
 
5.17.3
JURISDICTION ANALYSIS
 
 
6
MEDICAL FILTRATION MARKET, BY MATERIAL
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 4 Data Tables
 
 
 
87
 
6.1
INTRODUCTION
 
 
 
 
6.2
POLYSULFONE & POLYETHERSULFONE
 
 
 
 
 
6.2.1
EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET
 
 
 
6.3
POLYVINYLIDENE FLUORIDE
 
 
 
 
 
6.3.1
EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET
 
 
 
6.4
POLYTETRAFLUOROETHYLENE
 
 
 
 
 
6.4.1
SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND
 
 
 
6.5
POLYPROPYLENE
 
 
 
 
 
6.5.1
EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND
 
 
 
6.6
OTHER MATERIALS
 
 
 
7
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 4 Data Tables
 
 
 
93
 
7.1
INTRODUCTION
 
 
 
 
7.2
ULTRAFILTRATION
 
 
 
 
 
7.2.1
INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET
 
 
 
7.3
MICROFILTRATION
 
 
 
 
 
7.3.1
GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND
 
 
 
7.4
NANOFILTRATION
 
 
 
 
 
7.4.1
LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH
 
 
 
7.5
REVERSE OSMOSIS
 
 
 
 
 
7.5.1
CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET
 
 
 
7.6
GAS FILTRATION
 
 
 
 
 
7.6.1
DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH
 
 
 
7.7
OTHER PROCESS TECHNOLOGIES
 
 
 
8
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 4 Data Tables
 
 
 
99
 
8.1
INTRODUCTION
 
 
 
 
8.2
SYSTEMS (RTU UNITS)
 
 
 
 
 
8.2.1
CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET
 
 
 
8.3
FILTRATION MODULES (CONSUMABLES)
 
 
 
 
 
8.3.1
RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE
 
 
 
8.4
OTHER DESIGNS/PROCESSES
 
 
 
9
MEDICAL FILTRATION MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 4 Data Tables
 
 
 
103
 
9.1
INTRODUCTION
 
 
 
 
9.2
HOSPITALS
 
 
 
 
 
9.2.1
REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET
 
 
 
9.3
DIAGNOSTIC CENTERS
 
 
 
 
 
9.3.1
DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH
 
 
 
9.4
RESEARCH INSTITUTES
 
 
 
 
 
9.4.1
INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET
 
 
 
9.5
OTHER END USERS
 
 
 
10
MEDICAL FILTRATION MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 4 Data Tables
 
 
 
108
 
10.1
INTRODUCTION
 
 
 
 
10.2
DIALYSIS
 
 
 
 
 
10.2.1
ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH
 
 
 
10.3
DRUG DELIVERY
 
 
 
 
 
10.3.1
PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH
 
 
 
10.4
IV INFUSION & STERILE FILTRATION
 
 
 
 
 
10.4.1
HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH
 
 
 
10.5
ENDOSCOPY
 
 
 
 
 
10.5.1
ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET
 
 
 
10.6
STERILE PROCESSING
 
 
 
 
 
10.6.1
GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET
 
 
 
10.7
BIO-ARTIFICIAL PROCESSES
 
 
 
 
 
10.7.1
VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET
 
 
 
10.8
OTHER APPLICATIONS
 
 
 
11
MEDICAL FILTRATION MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 16 Countries | 208 Data Tables.
 
 
 
115
 
11.1
INTRODUCTION
 
 
 
 
11.2
ASIA PACIFIC
 
 
 
 
 
11.2.1
CHINA
 
 
 
 
 
11.2.1.1
STRONG ECONOMIC GROWTH AND EXPANDING HEALTHCARE SECTOR TO DRIVE MARKET
 
 
 
11.2.2
JAPAN
 
 
 
 
 
11.2.2.1
GROWING AGING POPULATION TO PROPEL MARKET
 
 
 
11.2.3
INDIA
 
 
 
 
 
11.2.3.1
INCREASING INVESTMENTS IN HEALTHCARE SECTOR TO DRIVE MARKET
 
 
 
11.2.4
SOUTH KOREA
 
 
 
 
 
11.2.4.1
RISING DEMAND FOR HIGH-QUALITY MEDICAL FILTRATION SOLUTIONS TO DRIVE MARKET
 
 
 
11.2.5
REST OF ASIA PACIFIC
 
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
GERMANY
 
 
 
 
 
11.3.1.1
ECONOMIC STRENGTH, INCREASING HEALTHCARE EXPENDITURE, AND RAPIDLY AGING POPULATION TO DRIVE MARKET
 
 
 
11.3.2
UK
 
 
 
 
 
11.3.2.1
RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
 
 
 
11.3.3
FRANCE
 
 
 
 
 
11.3.3.1
AGING POPULATION AND ENHANCEMENT OF HEALTHCARE SYSTEM TO PROPEL MARKET
 
 
 
11.3.4
ITALY
 
 
 
 
 
11.3.4.1
GROWING AGING POPULATION TO INCREASE DEMAND
 
 
 
11.3.5
SPAIN
 
 
 
 
 
11.3.5.1
RISING DEMAND FOR ADVANCED MEDICAL SOLUTIONS TO PROPEL MARKET
 
 
 
11.3.6
REST OF EUROPE
 
 
 
11.4
NORTH AMERICA
 
 
 
 
 
11.4.1
US
 
 
 
 
 
11.4.1.1
STRINGENT REGULATORY GUIDELINES AND INCREASING HEALTHCARE SPENDING TO BOOST MARKET
 
 
 
11.4.2
CANADA
 
 
 
 
 
11.4.2.1
GROWING AGING POPULATION AND SIGNIFICANT GOVERNMENT INVESTMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET GROWTH
 
 
 
11.4.3
MEXICO
 
 
 
 
 
11.4.3.1
GOVERNMENT INITIATIVES AND GROWTH OF HEALTHCARE SECTOR TO DRIVE MARKET
 
 
11.5
MIDDLE EAST & AFRICA
 
 
 
 
 
11.5.1
GCC COUNTRIES
 
 
 
 
 
11.5.1.1
SAUDI ARABIA
 
 
 
 
11.5.1.2
REST OF GCC COUNTRIES
 
 
 
11.5.2
SOUTH AFRICA
 
 
 
 
 
11.5.2.1
OUTBREAKS OF CONTAGIOUS DISEASES TO DRIVE DEMAND
 
 
 
11.5.3
REST OF MIDDLE EAST & AFRICA
 
 
 
11.6
SOUTH AMERICA
 
 
 
 
 
11.6.1
BRAZIL
 
 
 
 
 
11.6.1.1
RISING HEALTHCARE INVESTMENTS AND EXPANDING MEDICAL INFRASTRUCTURE TO PROPEL GROWTH
 
 
 
11.6.2
ARGENTINA
 
 
 
 
 
11.6.2.1
INCREASING HEALTHCARE EXPENDITURE AND ENHANCEMENT OF MEDICAL INFRASTRUCTURE TO DRIVE MARKET
 
 
 
11.6.3
REST OF SOUTH AMERICA
 
 
12
COMPETITIVE LANDSCAPE
Discover market leaders' winning strategies and emerging competitors reshaping the industry landscape.
 
 
 
200
 
12.1
OVERVIEW
 
 
 
 
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
12.3
REVENUE ANALYSIS, 2021–2023
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS, 2023
 
 
 
 
 
12.5
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
12.6
PRODUCT COMPARISON
 
 
 
 
 
12.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
12.7.1
STARS
 
 
 
 
12.7.2
EMERGING LEADERS
 
 
 
 
12.7.3
PERVASIVE PLAYERS
 
 
 
 
12.7.4
PARTICIPANTS
 
 
 
 
12.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
12.7.5.1
REGION FOOTPRINT
 
 
 
 
12.7.5.2
MATERIAL FOOTPRINT
 
 
 
 
12.7.5.3
PROCESS TECHNOLOGY FOOTPRINT
 
 
 
 
12.7.5.4
DESIGN/PROCESS FOOTPRINT
 
 
 
 
12.7.5.5
APPLICATION FOOTPRINT
 
 
 
 
12.7.5.6
END USER FOOTPRINT
 
 
12.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
12.8.1
PROGRESSIVE COMPANIES
 
 
 
 
12.8.2
RESPONSIVE COMPANIES
 
 
 
 
12.8.3
DYNAMIC COMPANIES
 
 
 
 
12.8.4
STARTING BLOCKS
 
 
 
 
12.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
 
 
12.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
12.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
12.9
COMPETITIVE SCENARIO
 
 
 
 
 
12.9.1
PRODUCT LAUNCHES
 
 
 
 
12.9.2
DEALS
 
 
 
 
12.9.3
EXPANSIONS
 
 
 
 
12.9.4
OTHER DEVELOPMENTS
 
 
13
COMPANY PROFILES – MEDICAL FILTRATION EQUIPMENT PROVIDERS
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
224
 
13.1
KEY PLAYERS
 
 
 
 
 
13.1.1
MERCK KGAA
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
13.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
13.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.1.1.4
MNM VIEW
 
 
 
13.1.2
3M (SOLVENTUM)
 
 
 
 
13.1.3
DANAHER
 
 
 
 
13.1.4
SARTORIUS AG
 
 
 
 
13.1.5
ASAHI KASEI CORPORATION
 
 
 
 
13.1.6
BAXTER
 
 
 
 
13.1.7
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
13.1.8
VEOLIA
 
 
 
 
13.1.9
DONALDSON COMPANY, INC.
 
 
 
 
13.1.10
PARKER HANNIFIN CORP
 
 
 
 
13.1.11
ENTEGRIS
 
 
 
 
13.1.12
MANN+HUMMEL
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
13.2.1
CORNING INCORPORATED
 
 
 
 
13.2.2
CRITICAL PROCESS FILTRATION, INC.
 
 
 
 
13.2.3
COBETTER
 
 
 
 
13.2.4
GRAVER TECHNOLOGIES
 
 
 
 
13.2.5
ERTELALSOP
 
 
 
 
13.2.6
KASAG SWISS AG
 
 
 
 
13.2.7
FILTROX AG
 
 
 
 
13.2.8
MEMBRANE SOLUTIONS
 
 
 
 
13.2.9
COLE-PARMER INSTRUMENT COMPANY, LLC
 
 
 
 
13.2.10
MEISSNER FILTRATION PRODUCTS, INC.
 
 
 
 
13.2.11
MEDICAL FILTRATION SOLUTIONS LTD.
 
 
 
 
13.2.12
SEFAR AG
 
 
 
 
13.2.13
WALKER FILTRATION
 
 
 
 
13.2.14
SAINT-GOBAIN
 
 
14
COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
294
 
14.1
KEY PLAYERS
 
 
 
 
 
14.1.1
STERIS
 
 
 
 
 
14.1.1.1
BUSINESS OVERVIEW
 
 
 
 
14.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
14.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
14.1.1.4
MNM VIEW
 
 
 
14.1.2
FORTIVE
 
 
 
 
14.1.3
OLYMPUS CORPORATION
 
 
 
 
14.1.4
ECOLAB
 
 
 
 
14.1.5
GETINGE
 
 
 
 
14.1.6
STEELCOBELIMED (METALL ZUG GROUP)
 
 
 
 
14.1.7
ENDO-TECHNIK W. GRIESAT (CREO)
 
 
 
 
14.1.8
WASSENBURG MEDICAL B.V. (HOYA CORPORATION)
 
 
15
COMPANY PROFILES – DIALYSIS EQUIPMENT PROVIDERS
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
321
 
15.1
KEY PLAYERS
 
 
 
 
 
15.1.1
FRESENIUS MEDICAL CARE AG
 
 
 
 
 
15.1.1.1
BUSINESS OVERVIEW
 
 
 
 
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
15.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
15.1.1.4
MNM VIEW
 
 
 
15.1.2
BAXTER
 
 
 
 
15.1.3
DAVITA INC.
 
 
 
 
15.1.4
NIKKISO CO., LTD.
 
 
 
 
15.1.5
B. BRAUN SE
 
 
 
 
15.1.6
NIPRO
 
 
 
 
15.1.7
TORAY MEDICAL CO., LTD.
 
 
 
 
15.1.8
MEDIONICS
 
 
16
APPENDIX
 
 
 
347
 
16.1
DISCUSSION GUIDE
 
 
 
 
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
16.3
CUSTOMIZATION OPTIONS
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
CAPITAL HEALTHCARE EXPENDITURE, 2020–2023 (USD MILLION)
 
 
 
 
TABLE 2
HEALTHCARE SPENDING, 2023 (USD MILLION)
 
 
 
 
TABLE 3
MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 4
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
 
 
 
 
TABLE 5
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
TABLE 6
PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019–2023
 
 
 
 
TABLE 7
ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR KEY COUNTRIES, 2024–2029
 
 
 
 
TABLE 8
HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019–2022
 
 
 
 
TABLE 9
MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
 
 
 
 
TABLE 10
NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
EXPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 14
IMPORT SCENARIO FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
TABLE 15
MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
 
 
 
 
TABLE 16
MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 17
MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 18
MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 19
MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 20
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 21
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 22
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 23
MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 24
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 25
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 26
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 27
MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 28
MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 29
MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 30
MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 31
MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 32
MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 33
MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 34
MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 35
MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 36
MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (UNIT)
 
 
 
 
TABLE 37
MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (UNIT)
 
 
 
 
TABLE 38
MEDICAL FILTRATION MARKET, BY REGION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 39
MEDICAL FILTRATION MARKET, BY REGION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 40
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
 
 
 
 
TABLE 41
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
 
 
 
 
TABLE 42
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 43
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 44
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 45
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 46
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 47
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 48
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 49
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 50
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 51
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 52
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 53
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 54
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 55
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 56
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 57
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 58
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 59
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 60
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 61
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 62
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 63
ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 64
CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 65
CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 66
CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 67
CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 68
JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 69
JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 70
JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 71
JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 72
INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 73
INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 74
INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 75
INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 76
SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 77
SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 78
SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 79
SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 80
REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 81
REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 82
REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 83
REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 84
EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
 
 
 
 
TABLE 85
EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
 
 
 
 
TABLE 86
EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 87
EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 88
EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 89
EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 90
EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 91
EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 92
EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 93
EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 94
EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 95
EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 96
EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 97
EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 98
EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 99
EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 100
EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 101
EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 102
EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 103
EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 104
EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 105
EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 106
EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 107
EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 108
GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 109
GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 110
GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 111
GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 112
UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 113
UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 114
UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 115
UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 116
FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 117
FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 118
FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 119
FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 120
ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 121
ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 122
ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 123
ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 124
SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 125
SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 126
SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 127
SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 128
REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 129
REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 130
REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 131
REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 132
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
 
 
 
 
TABLE 133
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
 
 
 
 
TABLE 134
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 135
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 136
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 137
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 138
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 139
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 140
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 141
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 142
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 143
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 144
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 145
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 146
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 147
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 148
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 149
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 150
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 151
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 152
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 153
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 154
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 155
NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 156
US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 157
US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 158
US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 159
US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 160
CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 161
CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 162
CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 163
CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 164
MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 165
MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 166
MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 167
MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 168
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
 
 
 
 
TABLE 169
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
 
 
 
 
TABLE 170
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 171
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 172
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 173
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 174
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 175
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 176
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 177
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 178
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 179
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 180
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 181
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 182
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 183
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 184
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 185
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 186
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 187
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 188
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 189
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 190
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 191
MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 192
SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 193
SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 194
SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 195
SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 196
REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 197
REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 198
REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 199
REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 200
SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 201
SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 202
SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 203
SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 204
REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 205
REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 206
REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 207
REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 208
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (UNIT)
 
 
 
 
TABLE 209
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (UNIT)
 
 
 
 
TABLE 210
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 211
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 212
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (UNIT)
 
 
 
 
TABLE 213
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (UNIT)
 
 
 
 
TABLE 214
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 215
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 216
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (UNIT)
 
 
 
 
TABLE 217
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (UNIT)
 
 
 
 
TABLE 218
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 219
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 220
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (UNIT)
 
 
 
 
TABLE 221
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (UNIT)
 
 
 
 
TABLE 222
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 223
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 224
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (UNIT)
 
 
 
 
TABLE 225
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (UNIT)
 
 
 
 
TABLE 226
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 227
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 228
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 229
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 230
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 231
SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 232
BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 233
BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 234
BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 235
BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 236
ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 237
ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 238
ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 239
ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 240
REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (UNIT)
 
 
 
 
TABLE 241
REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (UNIT)
 
 
 
 
TABLE 242
REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021–2023 (USD MILLION)
 
 
 
 
TABLE 243
REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024–2030 (USD MILLION)
 
 
 
 
TABLE 244
MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 245
MEDICAL FILTRATION MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 246
MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT
 
 
 
 
TABLE 247
MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT
 
 
 
 
TABLE 248
MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT
 
 
 
 
TABLE 249
MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 250
MEDICAL FILTRATION MARKET: END USER FOOTPRINT
 
 
 
 
TABLE 251
MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES
 
 
 
 
TABLE 252
MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
TABLE 253
MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 254
MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 255
MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 256
MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 257
MERCK KGAA: COMPANY OVERVIEW
 
 
 
 
TABLE 258
MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 259
MERCK KGAA: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 260
3M (SOLVENTUM): COMPANY OVERVIEW
 
 
 
 
TABLE 261
3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 262
3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 263
DANAHER: COMPANY OVERVIEW
 
 
 
 
TABLE 264
DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 265
DANAHER: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 266
DANAHER: OTHERS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 267
SARTORIUS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 268
SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 269
SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 270
ASAHI KASEI CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 271
ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 272
BAXTER: COMPANY OVERVIEW
 
 
 
 
TABLE 273
BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 274
BAXTER: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 275
THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 276
THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 277
VEOLIA: COMPANY OVERVIEW
 
 
 
 
TABLE 278
VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 279
VEOLIA: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 280
DONALDSON COMPANY, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 281
DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 282
DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 283
PARKER HANNIFIN CORP: COMPANY OVERVIEW
 
 
 
 
TABLE 284
PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 285
ENTEGRIS: COMPANY OVERVIEW
 
 
 
 
TABLE 286
ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 287
MANN+HUMMEL: COMPANY OVERVIEW
 
 
 
 
TABLE 288
MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 289
CORNING INCORPORATED: COMPANY OVERVIEW
 
 
 
 
TABLE 290
CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 291
COBETTER: COMPANY OVERVIEW
 
 
 
 
TABLE 292
GRAVER TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
TABLE 293
ERTELALSOP: COMPANY OVERVIEW
 
 
 
 
TABLE 294
KASAG SWISS AG: COMPANY OVERVIEW
 
 
 
 
TABLE 295
FILTROX AG: COMPANY OVERVIEW
 
 
 
 
TABLE 296
MEMBRANE SOLUTIONS: COMPANY OVERVIEW
 
 
 
 
TABLE 297
COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 298
MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 299
MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 300
SEFAR AG: COMPANY OVERVIEW
 
 
 
 
TABLE 301
WALKER FILTRATION: COMPANY OVERVIEW
 
 
 
 
TABLE 302
SAINT-GOBAIN: COMPANY OVERVIEW
 
 
 
 
TABLE 303
STERIS: COMPANY OVERVIEW
 
 
 
 
TABLE 304
STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 305
STERIS: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 306
FORTIVE: COMPANY OVERVIEW
 
 
 
 
TABLE 307
FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 308
FORTIVE: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 309
OLYMPUS CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 310
OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 311
OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 312
ECOLAB: COMPANY OVERVIEW
 
 
 
 
TABLE 313
ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 314
ECOLAB: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 315
GETINGE: COMPANY OVERVIEW
 
 
 
 
TABLE 316
GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 317
GETINGE: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 318
STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW
 
 
 
 
TABLE 319
STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
TABLE 320
STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 321
ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW
 
 
 
 
TABLE 322
ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 323
WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW
 
 
 
 
TABLE 324
WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 325
WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 326
FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
 
 
 
 
TABLE 327
FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 328
FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 329
FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 330
BAXTER: COMPANY OVERVIEW
 
 
 
 
TABLE 331
BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 332
BAXTER: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 333
DAVITA INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 334
DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 335
DAVITA INC.: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 336
DAVITA INC.: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 337
NIKKISO CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 338
NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 339
NIKKISO CO., LTD.: DEALS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 340
B. BRAUN SE: COMPANY OVERVIEW
 
 
 
 
TABLE 341
B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 342
B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 343
B. BRAUN SE: EXPANSIONS, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 344
NIPRO: COMPANY OVERVIEW
 
 
 
 
TABLE 345
NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 346
NIPRO: PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2025
 
 
 
 
TABLE 347
TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 348
TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
TABLE 349
MEDIONICS: COMPANY OVERVIEW
 
 
 
 
TABLE 350
MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
MEDICAL FILTRATION MARKET AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
MEDICAL FILTRATION MARKET: RESEARCH DESIGN
 
 
 
 
FIGURE 3
MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH
 
 
 
 
FIGURE 4
MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH
 
 
 
 
FIGURE 5
MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH)
 
 
 
 
FIGURE 6
DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
 
 
 
 
FIGURE 7
MEDICAL FILTRATION MARKET: DATA TRIANGULATION
 
 
 
 
FIGURE 8
POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 9
DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 10
HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 11
ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 12
GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET
 
 
 
 
FIGURE 13
POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 14
IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 15
HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD
 
 
 
 
FIGURE 16
CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 17
DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET
 
 
 
 
FIGURE 18
MEDICAL FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 19
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
 
 
 
 
FIGURE 20
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
FIGURE 21
MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 22
MEDICAL FILTRATION MARKET: ECOSYSTEM
 
 
 
 
FIGURE 23
MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
FIGURE 24
EXPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
FIGURE 25
IMPORT DATA FOR HS CODE 8421–COMPLIANT PRODUCTS, BY COUNTRY, 2019–2023 (USD THOUSAND)
 
 
 
 
FIGURE 26
AVERAGE SELLING PRICE TREND, BY REGION, 2021–2023 (USD/UNIT)
 
 
 
 
FIGURE 27
AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021–2023 (USD/UNIT)
 
 
 
 
FIGURE 28
AVERAGE SELLING PRICE TREND, BY END USER, 2021–2023 (USD/UNIT)
 
 
 
 
FIGURE 29
INVESTMENT AND FUNDING SCENARIO, 2020–2024 (USD MILLION)
 
 
 
 
FIGURE 30
PATENTS APPLIED AND GRANTED, 2014–2024
 
 
 
 
FIGURE 31
LEGAL STATUS OF PATENTS, 2014–2024
 
 
 
 
FIGURE 32
TOP JURISDICTIONS
 
 
 
 
FIGURE 33
POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 34
MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 35
FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 36
HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 37
DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 38
ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 39
ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT
 
 
 
 
FIGURE 40
EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT
 
 
 
 
FIGURE 41
NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT
 
 
 
 
FIGURE 42
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024
 
 
 
 
FIGURE 43
REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021–2023
 
 
 
 
FIGURE 44
MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023
 
 
 
 
FIGURE 45
VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
 
 
 
 
FIGURE 46
FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
 
 
 
 
FIGURE 47
MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS
 
 
 
 
FIGURE 48
COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023
 
 
 
 
FIGURE 49
MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT
 
 
 
 
FIGURE 50
COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023
 
 
 
 
FIGURE 51
MERCK KGAA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
3M (SOLVENTUM): COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
DANAHER: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
SARTORIUS AG: COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
BAXTER: COMPANY SNAPSHOT
 
 
 
 
FIGURE 57
THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 58
VEOLIA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 59
DONALDSON COMPANY, INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 60
PARKER HANNIFIN CORP: COMPANY SNAPSHOT
 
 
 
 
FIGURE 61
ENTEGRIS: COMPANY SNAPSHOT
 
 
 
 
FIGURE 62
MANN+HUMMEL: COMPANY SNAPSHOT
 
 
 
 
FIGURE 63
STERIS: COMPANY SNAPSHOT
 
 
 
 
FIGURE 64
FORTIVE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 65
OLYMPUS CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 66
ECOLAB: COMPANY SNAPSHOT
 
 
 
 
FIGURE 67
GETINGE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 68
STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT
 
 
 
 
FIGURE 69
FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
 
 
 
 
FIGURE 70
BAXTER: COMPANY SNAPSHOT
 
 
 
 
FIGURE 71
DAVITA INC.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 72
NIKKISO CO., LTD.: COMPANY SNAPSHOT
 
 
 
 
FIGURE 73
B. BRAUN SE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 74
NIPRO: COMPANY SNAPSHOT
 
 
 
 
FIGURE 75
TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT
 
 
 
 

Methodology

The study involved four major activities in estimating the market size of the medical filtration market. Exhaustive secondary research was done to collect information on the market, the peer market, and the grandparent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources have been referred to for identifying and collecting information for this study. These secondary sources include annual reports, press releases, investor presentations of companies, white papers, certified publications, trade directories, articles from recognized authors, gold standard and silver standard websites, and databases. Secondary research has been used to obtain key information about the value chain of the industry, monetary chain of the market, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, and regional markets. It was also used to obtain information about the key developments from a market-oriented perspective.

Primary Research

The medical filtration market comprises several stakeholders in the value chain, which include manufacturers, and end users. Various primary sources from the supply and demand sides of the medical filtration market have been interviewed to obtain qualitative and quantitative information. The primary interviewees from the demand side include key opinion leaders in industrial sectors. The primary sources from the supply side include manufacturers, associations, and institutions involved in the medical filtration industry. Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to type, material, end-use industry, and region. Stakeholders from the demand side, such as CIOs, CTOs, and CSOs were interviewed to understand the buyer’s perspective on the suppliers, products, component providers, and their current usage of medical filtration and outlook of their business, which will affect the overall market.

The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Medical Filtration Market

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022 available in the public domain, product portfolios, and geographical presence.

Other designations include consultants and sales, marketing, and procurement managers.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches have been used to estimate and validate the size of the medical filtration market.

  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research includes the study of reports, reviews, and newsletters of the key market players, along with extensive interviews for opinions with leaders such as directors and marketing executives.
Medical Filtration Market

Data Triangulation

After arriving at the total market size from the estimation process, the overall market has been split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments, the data triangulation and market breakdown procedures have been employed, wherever applicable. The data has been triangulated by studying various factors and trends from both the demand and supply sides. Along with this, the market size has been validated by using both the top-down and bottom-up approaches and primary interviews. Hence, for every data segment, there have been three sources—top-down approach, bottom-up approach, and expert interviews. The data was assumed correct when the values arrived from the three sources matched.

Market Definition

Medical filtration is the process that separates solid particles from fluids (liquids or gases) with the use of filter media which allows only the fluid to pass through it and retains the solid matter. This process inevitable in the healthcare settings for ensuring purity of air and fluids to enhance patient safety and improve the effectiveness of medical devices and procedures.

Stakeholders

  • Senior Management
  • End User
  • Finance/Procurement Department
  • R&D Department
  • Manufacturers
  • Raw Material Suppliers

Report Objectives

  • To define, describe, and forecast the size of the medical filtration market, in terms of value and volume.
  • To provide detailed information regarding the major factors (drivers, opportunities, restraints, and challenges) influencing the growth of the market
  • To estimate and forecast the market size based on type, technology, application, end-use industry, and region.
  • To forecast the size of the market with respect to major regions, namely, Europe, North America, Asia Pacific, Middle East & Africa, and South America, along with their key countries
  • To strategically analyze micro-markets with respect to individual growth trends, prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape of market leaders.
  • To track and analyze recent developments such as expansions, new product launches, partnerships & agreements, and acquisitions in the market.
  • To strategically profile key market players and comprehensively analyze their core competencies.

 

Key Questions Addressed by the Report

What is the current size of the global medical filtration market?
The global medical filtration market is estimated to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8% during the forecast period.
Who are the key players in the global medical filtration market?
Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc. (US), Donaldson Company Inc. (US), Baxter (US), Parker Hannifin Corp. (US), Entegris (US), Asahi Kasei Corporation (Japan), and MANN+HUMMEL (Germany) are the key players in this market. They have the potential to broaden their product portfolio and compete with other key market players.
What are some of the drivers for the market growth?
Key drivers for the medical filtration market include the growing demand for high-quality filtration solutions and the growing focus on infection control.
What are the different materials used in medical filtrations?
PES, PVDF, PTFE, and PP are widely used in this market.
What are the major end-use industries of medical filtration?
Hospitals, diagnostics centers, and research institutes are the main end-users in this market.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Filtration Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Medical Filtration Market

DMCA.com Protection Status